Search results
Author(s):
Michelle Kittleson
Added:
1 year ago
In this video, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, Los Angeles, CA, US) provides her expert opinion on the 2022 ACC guidelines for the management of Heart Failure. Dr Kittleson outlines the applicability of these recommendations, as well as the barriers and opportunities.
Recorded remotely from Beverley-Hills, 2022.
Interviewer: Mirjam Boros
View more
Author(s):
Jose A Joglar
Added:
1 month ago
Dr Jose Joglar (UT Southwestern, US) joins us virtually to discuss the 2023 guidelines for atrial fibrillation (AF) diagnosis and management.These guidelines are an update to the 2014 document covering the full spectrum of managing patients with AF, from prevention to lifetime interventions, to rhythm and rate control, as well as special populations. A new classification of AF has been created,…
View more
Author(s):
Neal M Dixit
,
Shivani Shah
,
Boback Ziaeian
,
et al
Added:
2 years ago
Start date:
Aug 27, 2023
End date:
Aug 27, 2023
Radcliffe Medical Education present a satellite symposium entitled ‘Implementing Heart Failure Guidelines with Collaborative Care’ at the ESC Congress 2023 in Amsterdam, NL. Join us in the Riga Lecture Room, or online, on Sunday 27 August 2023, from 12:45 to 13:45 CEST.
This session, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity for…
View more
George L Bakris
Research Area(s) / Expertise:
Job title: President Elect
Author
Alun Davies
Job title: Professor of vascular surgery and honorary consultant
Author
ESC 23: LODESTAR Trial
Author(s):
Myeong-Ki Hong
Added:
6 months ago
Video
Author(s):
Robert A Byrne
Added:
6 months ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes.
Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation…
View more
Author(s):
Duk-Woo Park
Added:
1 year ago
In this short interview, Dr Duk-Woo Park (Asan Medical Center, KR) discusses the findings from the ADAPT-TAVR Randomized Clinical Trial (NCT03284827).
The trial investigated Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR.
Presented first at ACC.22, ADAPT-TAVR shows that the overall incidence of leaflet thrombosis on CT scans was less…
View more
Author(s):
Felix Mahfoud
Added:
1 year ago
In this short late-breaking interview, Prof Felix Mahfoud (Saarland University Hospital, DE) discusses the 3-year efficacy outcomes of the SPYRAL HTN-ON MED Pilot Study (NCT02439775). The global clinical study, presented at ACC.22, tested the long-term effect of renal denervation (Symplicity Spyral™ multi-electrode renal denervation system, Medtronic Vascular) on blood pressure reduction in…
View more